| Characterization and subcellular localization of an RNA silencing suppressor encoded by Rice stripe tenuivirus R Xiong, J Wu, Y Zhou, X Zhou Virology 387 (1), 29-40, 2009 | 213 | 2009 |
| Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly F Gatto, RA Feelders, R van der Pas, JM Kros, M Waaijers, D Sprij-Mooij, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), E66-E71, 2013 | 169 | 2013 |
| Conventional and nuclear medicine imaging in ectopic Cushing's syndrome: a systematic review AM Isidori, E Sbardella, MC Zatelli, M Boschetti, G Vitale, A Colao, ... The Journal of Clinical Endocrinology & Metabolism 100 (9), 3231-3244, 2015 | 137 | 2015 |
| Somatostatin receptor ligands in the treatment of acromegaly MR Gadelha, LE Wildemberg, MD Bronstein, F Gatto, D Ferone Pituitary 20, 100-108, 2017 | 129 | 2017 |
| The role of somatostatin and dopamine D2 receptors in endocrine tumors F Gatto, LJ Hofland Endocrine Related Cancer 18 (6), R233, 2011 | 99 | 2011 |
| The clinical–molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology D Ferone, F Gatto, M Arvigo, E Resmini, M Boschetti, C Teti, D Esposito, ... Journal of molecular endocrinology 42 (5), 361-370, 2009 | 99 | 2009 |
| Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors G Gaudenzi, M Albertelli, A Dicitore, R Würth, F Gatto, F Barbieri, F Cotelli, ... Endocrine 57, 214-219, 2017 | 92 | 2017 |
| Phenotypical and pharmacological characterization of stem-like cells in human pituitary adenomas R Würth, F Barbieri, A Pattarozzi, G Gaudenzi, F Gatto, P Fiaschi, ... Molecular Neurobiology 54, 4879-4895, 2017 | 64 | 2017 |
| In vitro head-to-head comparison between octreotide and pasireotide in GH-secreting pituitary adenomas F Gatto, RA Feelders, SE Franck, PM van Koetsveld, F Dogan, JM Kros, ... The Journal of Clinical Endocrinology & Metabolism 102 (6), 2009-2018, 2017 | 64 | 2017 |
| β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients … F Gatto, R Feelders, R van der Pas, JM Kros, F Dogan, PM van Koetsveld, ... Endocrinology 154 (12), 4715-4725, 2013 | 64 | 2013 |
| Balance between somatostatin and D2 receptor expression drives TSH‐secreting adenoma response to somatostatin analogues and dopastatins F Gatto, F Barbieri, M Gatti, R Wurth, S Schulz, JL Ravetti, G Zona, ... Clinical endocrinology 76 (3), 407-414, 2012 | 62 | 2012 |
| Novel chimeric somatostatin analogs: facts and perspectives D Ferone, A Saveanu, MD Culler, M Arvigo, A Rebora, F Gatto, F Minuto, ... European journal of endocrinology 156 (Supplement_1), S23-S28, 2007 | 61 | 2007 |
| Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first … F Gatto, LF Grasso, E Nazzari, T Cuny, P Anania, C Di Somma, A Colao, ... Pituitary 18, 583-591, 2015 | 59 | 2015 |
| Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly F Gatto, NR Biermasz, RA Feelders, JM Kros, F Dogan, AJ van der Lely, ... European Journal of Endocrinology 174 (5), 651-662, 2016 | 54 | 2016 |
| Global epidemiology of acromegaly: a systematic review and meta-analysis S Crisafulli, N Luxi, J Sultana, A Fontana, F Spagnolo, G Giuffrida, ... European journal of endocrinology 185 (2), 251-263, 2021 | 53 | 2021 |
| Pasireotide responsiveness in acromegaly is mainly driven by somatostatin receptor subtype 2 expression A Muhammad, EC Coopmans, F Gatto, SE Franck, JA Janssen, ... The Journal of Clinical Endocrinology & Metabolism 104 (3), 915-924, 2019 | 50 | 2019 |
| Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro … R van der Pas, RA Feelders, F Gatto, C de Bruin, AM Pereira, ... The Journal of Clinical Endocrinology & Metabolism 98 (12), E1880-E1890, 2013 | 48 | 2013 |
| In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 F Gatto, F Barbieri, L Castelletti, M Arvigo, A Pattarozzi, F Annunziata, ... Pituitary 14, 141-147, 2011 | 47 | 2011 |
| Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines M Arvigo, F Gatto, M Ruscica, P Ameri, E Dozio, M Albertelli, MD Culler, ... Journal of Endocrinology 207 (3), 309, 2010 | 44 | 2010 |
| Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database F Gatto, G Trifirò, F Lapi, F Cocchiara, C Campana, C Dell’Aquila, ... Endocrine 61, 533-541, 2018 | 36 | 2018 |
